Mirabella Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mirabella Financial Services’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,040	Closed	-$4.97M	–	343
2022 Q2	$4.97M	Buy	10,040 +4,775	+91%	+$2.49M	0.49%	41
2022 Q1	$2.97M	Sell	5,265 -10,495	-67%	-$6.33M	0.33%	49
2021 Q4	$11.9M	Buy	15,760 +9,012	+134%	+$6.74M	1.21%	10
2021 Q3	$5.03M	Sell	6,748 -6,398	-49%	-$4.79M	0.66%	43
2021 Q2	$8.47M	Sell	13,146 -689	-5%	-$419K	1.52%	11
2021 Q1	$7.9M	Buy	13,835 +3,829	+38%	+$2.27M	2.45%	6
2020 Q4	$5.83M	Buy	10,006 +8,912	+815%	+$5.08M	0.73%	54
2020 Q3	$564K	Buy	+1,094	New	+$554K	0.08%	126

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mirabella Financial Services's BIO Position: Q3 2022 in Review

Mirabella Financial Services sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 10,040 shares — an estimated $4.97M sold.

Mirabella Financial Services first reported a position in BIO in Q3 2020 and held it in 8 quarters. The position peaked at $11.9M in Q4 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

Mirabella Financial Services reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
Mirabella Financial Services sold 10,040 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $4.97M.
Mirabella Financial Services first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 8 quarters.
Mirabella Financial Services's Bio-Rad Laboratories Class A position peaked at $11.9M in Q4 2021.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Mirabella Financial Services's 13F filing for Q3 2022, filed 26 Oct 2022.